Showing results (11-20 of 25) with videos related to
Sort By:
Pageof 3
Cell Host & Microbe|March 14, 2015
Structure and receptor binding of the hemagglutinin from a human H6N1 influenza virusNetanel Tzarum, Robert P de Vries, Xueyong Zhu, et al.Cell Host & Microbe|March 14, 2015
A human-infecting H10N8 influenza virus retains a strong preference for avian-type receptorsHeng Zhang, Robert P de Vries, Netanel Tzarum, et al.Cell Reports|October 21, 2016
HMGB1 Activates Proinflammatory Signaling via TLR5 Leading to AllodyniaNabanita Das, Varun Dewan, Peter M Grace, et al.Cell Reports|April 14, 2017
The 150-Loop Restricts the Host Specificity of Human H10N8 Influenza VirusNetanel Tzarum, Robert P de Vries, Wenjie Peng, et al.Science Advances|June 5, 2020
Proof of concept for rational design of hepatitis C virus E2 core nanoparticle vaccinesLinling He, Netanel Tzarum, Xiaohe Lin, et al.NPJ Vaccines|April 20, 2026
Structural and genetic signatures of two classes of HCV E2 neutralizing face antibodies from non-human primates immunized with a recombinant E1E2Yen T K Nguyen, Fang Chen, Erick Giang, et al.Science Advances|January 8, 2019
Genetic and structural insights into broad neutralization of hepatitis C virus by human VH1-69 antibodiesNetanel Tzarum, Erick Giang, Leopold Kong, et al.Plos Pathogens|December 19, 2017
Probing the antigenicity of hepatitis C virus envelope glycoprotein complex by high-throughput mutagenesisRadhika Gopal, Kelli Jackson, Netanel Tzarum, et al.Proceedings of the National Academy of Sciences of the United States of America|October 30, 2016
Structural flexibility at a major conserved antibody target on hepatitis C virus E2 antigenLeopold Kong, David E Lee, Rameshwar U Kadam, et al.Science Advances|August 6, 2020
An alternate conformation of HCV E2 neutralizing face as an additional vaccine targetNetanel Tzarum, Erick Giang, Rameshwar U Kadam, et al.Pageof 3